The human hematopoietic stem cell (HSC) compartment represents the best candidate for the treatment of various genetic hemopathies by gene therapy. However, in adults, most hematopoietic stem cells are quiescent and retroviral vectors can be integrated only into dividing cells. Transforming growth factor-␤1 (TGF-␤1) is an important regulator of cell proliferation during development. [1] [2] [3] This is particularly true in the hematopoietic system where TGF-␤1 controls stem/progenitor cell proliferation, differentiation and survival. 4 Our group has particularly studied the mechanisms by which TGF-␤1 controls early cell cycles of human hematopoietic stem/progenitor cells. We have shown, that by neutralizing the effects of autocrine or endogenous TGF-␤1 with antisense oligonucleotides or blocking antibodies against TGF-␤1 5-7 or its type II receptor, 8 primitive HSC can be released from quiescence. Blocking the Rb gene or CDKI such as p27 by antisense oligonucleotides has similar effects. 5, 9 We have observed that the earlier high proliferative potential-mixed (HPP-Mix) are those which are inhibited by the lowest concentrations of TGF-␤1 (10 pg/ml), whereas later HPP-GM are only sensitive to concentrations between 100 and 300 pg/ml. 10 Still later pro- TGF-␤1 could induce reversion to quiescence of the more primitive CD34 + cells transduced after one cell cycle. This would prevent their subsequent detection in a classic clonal assay. Using the HPP-Q assay comparing a rapid mixed colony assay with or without anti-TGF-␤1, we indeed observed, that in clonal growth conditions the more primitive transduced cells were activated and detectable only with anti-TGF-␤1. Therefore, this assay represents not only a rapid means to detect quiescent multipotent stem/progenitor cells but also a necessary step for the detection of the more primitive transduced cells which have returned to quiescence after retroviral induction of TGF-␤1 secretion. Gene Therapy (2000) 7, 1790-1794.
genitors are poorly inhibited by higher concentrations. 10 We have previously described that activation by a short exposure to anti-TGF-␤1 for no more than 10 h significantly increased gene transfer in HSCs. 11 In view of the high and selective sensitivity to TGF-␤1 of the most primitive progenitor cells, we wondered whether, after transduction, these cells could return to quiescence and would thus be undetectable in a classic clonal culture assay. This would be particularly the case if the retroviral supernatant itself could induce TGF-␤1 in CD34 + cells. It is interesting to note that Steinman et al 13 observed in HL60 cells (promyelocytic leukemia cells) that the process of transduction up-regulated p21 mRNA, a cyclindependent kinase inhibitor (CDKI) that blocked cell cycle progression. 12 We have recently shown that p21 cip1 is controlled by TGF-␤1 in early stem/progenitor cells. 13 In this study, we have therefore first tried to detect a possible induction of TGF-␤1 by retroviral supernatant and then used the high proliferative potential-quiescent (HPP-Q) cell assay 7 to detect gene transfer in the primitive cells which remain quiescent in response to very low concentrations of TGF-␤1. The HPP-Q assay allows the comparison of colonies obtained in a control medium containing an optimal cytokine combination with colonies obtained in a similar medium with added anti-TGF-␤1 (HPP-Q medium). The control medium reveals only pre-activated progenitors. In addition to these progenitors, the HPP-Q Figure 1 medium is able to activate high proliferative potentialquiescent stem/progenitor cells (HPP-Q cells). These quiescent progenitors can be quantified by the difference in the colony size and number observed between the two culture conditions. These primitive cells activated by the presence of anti-TGF-␤1 have a higher proliferative potential than the pre-activated progenitors. They provide larger mixed or GM colonies containing various hematopoietic lineages. [5] [6] [7] They respond to the inhibitory effect of very low endogenous concentrations of TGF-␤1. 10 In this study, we consider only the HPP-Q-Mix as they are the most primitive and could belong to the stem cell compartment. 4, 7, 8 To obtain optimal transduction in quiescent primitive cells, UCB CD34
+ cells were prestimulated for 10 h with anti-TGF-␤1, 11 and then incubated for four successive periods of 6 h each with fresh high-titer supernatants Gene Therapy from a MFG-nlsLacZ A7-21 producer clone on CH-296 fibronectin fragments. [14] [15] [16] [17] [18] To detect TGF-␤1 synthesis in human UCB CD34
+ cells during retroviral transduction, we have used a sensitive in situ hybridization (ISH) technique. 19 UCB CD34 + cells cultured with or without retroviral supernatant were harvested 6, 12, 18 and 24 h after the onset of culture and processed for ISH. Figure 1 shows the ratio of TGF-␤1 expressing cells after infection by a viral supernatant versus the control condition. In the viral supernatant condition, a progressive increase in TGF-␤1 expressing cells was observed with a peak after 12 h, corresponding to the second cycle of retroviral supernatant infection. At this time, 3.5 times more cells expressed TGF-␤1 as compared with the nontransduced cells which showed no increase. Moreover, when we analyzed the labeling distribution of these cells (Figure 2) , we observed that 80% of them were labeled and 36% expressed a high level of TGF-␤1 mRNA, presenting 60 to 120 grains per cell. In the control condition, on the contrary, only 27% of cells expressed TGF-␤1 mRNA and most of them contained less than 60 grains. Thus, we found that a high level of TGF-␤1 mRNA was produced during a multicycle infection, suggesting that most primitive progenitors could be transduced after activation with anti-TGF-␤1 but rapidly reverted to quiescence in response to TGF-␤1 produced during infection. This greater expression of TGF-␤1 could provide a mechanism for stem cell protection against viral infection, since TGF-␤1 allows cells to return to quiescence. As viral envelope proteins alone are able to induce interferon, 20 ,21 a similar mechanism may control TGF-␤1 production. It is interesting to note that the up-modulation of TGF-␤1 observed was rapid but transient. We have often observed similar transient phenomena when we studied the regulation of cytokine receptors in response to TGF-␤1 or anti-TGF-␤1. 22 In order to check the possibility that this induced TGF-␤1 could cause the most primitive transduced cells to
Figure 2 TGF-␤1 mRNA is expressed with a higher intensity and in a greater number of cells after exposure for 12 h to a retroviral supernatant. Purified UCB CD34 + cells were preactivated with anti-TGF␤1 and cultured for 12 h with or without retroviral supernatant and treated for ISH as described in the legend of Figure 1. Autoradiographic grains were counted by semi-automatic image analysis. The upper part of the figure shows the morphology of the cells hybridized with the sense

35
S-labeled riboprobe (a) or with the antisense 35 S-labeled riboprobe (b and c). The lower part of the figure shows the distribution of the population according to the labeling intensity. Cells containing less than 30 grains () were scored as 'negative', so all cells containing more than 30 grains () were scored as positive. Within the positive population, cells with more than 60 grains were considered as cells with high expression.
revert to quiescence after one or two cell divisions, we used the HPP-Q cell functional assay. 7 After the transduction procedure, UCB CD34 + were plated and cultured for 14 to 18 days in semi-solid medium with or without anti-TGF-␤1 (HPP-Q assay). The number of total colonies (CFC), the transduced CFC and the percentage of transfer were determined in both culture conditions. The transduction protocol did not generate any toxicity. Indeed, the clonogenicity of cells treated by the transduction protocol was not decreased in comparison with that obtained in HPP-Q assay with untreated cells 7 (not shown). The results showed an average increase of 12% in the total CFC obtained in the HPP-Q medium with anti-TGF-␤1 as compared with CM alone (246 ± 73 versus 215 ± 45) and of 19% for the total transduced CFC (66 ± 36 versus 53 ± 28). These values indicate a percentage of transduced CFC of around 25%. Previous results of transduction protocols using fibronectin fragments (CH-296) showed similar gene transfer efficiency, ranging from 15 to 20% into CFC. 23 However, these values did not indicate the proportion of primitive transduced stem/progenitor cells, the most relevant target for long-term engraftment. This important information was obtained when gene transfer was evaluated in the most primitive high proliferative potential CFU-Mix by the HPP-Q assay. We only present the results concerning the HPP-Q-Mix because they are the most primitive cells which can be characterized and assayed, both in the rapid in vitro HPP-Q assay 7 and in the long-term engraftment pre-immune fetal sheep assay. 24 They are also the best target for gene therapy.
4,11 Table 1 shows the number of mixed colonies (CFU-Mix) and transduced CFU-Mix obtained in control medium or in HPP-Q medium in four independent experiments. The number of total CFU-Mix significantly increased in the HPP-Q medium (26 versus 10). Most interestingly, within the total CFU-Mix population, anti-TGF-␤1 activation revealed more transduced CFU-Mix (14 versus one). In summary, as shown in Table 1 , in the control medium only one transduced CFU-Mix out of a total of 10 was detected (10%); in the HPP-Q medium, 14 transduced mixed colonies out of 26 were detected (54%) (P = 0.02 by using Fisher's exact test). Therefore, the HPP-Q assay revealed 13 additional transduced HPP-Q Mix out of a total of 16 HPP-Q Mix. Thus, using this assay we could reveal rapidly a high percentage of gene transfer (81%) in the more primitive quiescent progenitors, the cells which are the best candidates for long-term engraftment.
Our results suggest that the induction of autocrine or paracrine TGF-␤1 by retroviral supernatant causes a significant subpopulation of primitive stem/progenitor cells to revert to quiescence. These results are in agreement with recent studies in which we demonstrated that TGF-␤1 was able to abolish cytokine-induced growth of the more primitive hematopoietic cells when added at physiological concentrations as low as 10 pg/ml in the culture. Low TGF-␤1 concentrations maintained these primitive cells in an undividing or slow cycling state both in clonal liquid or semi-solid assays. 10, 25 The increase in TGF-␤1 mRNA observed during the transduction procedure explained why the HPP-Q assay, which activates One hundred thousand UCB CD34 + cells/ml were activated by a brief exposure (10 h) to NovaStem T medium containing anti-TGF-␤1 (NovaStem, Villejuif, France). Cells were resuspended in 2 ml of retroviral cell-free supernatant and incubated in 24-well tissue culture plates coated with the CH-296 C-terminal fragment of fibronectin. The multicycle infection was performed during 24 h at 37°C with 5% CO 2 in a saturated humidified atmosphere. After the transduction procedure, 400 UCB CD34
+ cells per condition were cultured in clonogenic HPP-Q assay (NovaStem) ie in control medium (CM) and CM + anti-TGF-␤1 (HPP-Q medium), in duplicate in four independent experiments. Only macroscopic mixed colonies with more than 10 5 cells were taken into account. Mixed colonies contained both erythroid cells and at least one or two myeloid lineages. The difference between total CFU-Mix in CM and HPP-Q conditions was calculated to determine the number of activated HPP-Q Mix revealed by the HPP-Q assay. Transduced CFU-Mix were determined after the X-gal staining procedure. To check the specificity of X-gal staining, gene transfer was evaluated using a second method. Colonies were sampled on a glass slide and labeled using fluorescein di-␤-galactoside (FDG), as described by MacGregor et al. the more primitive quiescent stem/progenitor cells, was necessary to detect the more primitive transduced clones.
It is important to note that the HPP-Q cells, in contrast to many other primitive stem/progenitor cells which have been described, can be phenotyped precisely. We know that these cells express TGF-␤1 and both type I and II TGF-␤ receptors. + human marrow cells that express low levels of Kit protein, corresponding to the HPP-Q cells allowed a long-term engraftment. 24 Several in vivo models have been developed to test the ability of human stem cells to repopulate immune-deficient mice such as the NOD/SCID mice. 26 However, such engraftment analysis cannot provide clinicians with a rapid routine diagnosis in a human gene therapy protocol. Therefore, the HPP-Q assay is not only a rapid means of revealing multipotent stem/progenitor cells but it also allows the quantification of gene transfer in primitive stem/progenitor cells which may easily return to quiescence after a prestimulated gene transfer procedure.
